Differential glycosylation of Bence Jones protein and kidney impairment in patients with plasma cell dyscrasia

Journal of Laboratory and Clinical Medicine

Volumn 129, Issue 2, 1997, Pages 217-223

  Kagimoto, Tadashi ^a   Nakakuma, Hideki ^b   Hata, Hiroyuki ^b   Hidaka, Michihiro ^b   Horikawa, Kentaro ^b   Kawaguti, Tatsuya ^b   Nagakura, Shoichi ^b   Iwamoto, Norihiro ^b   Shirono, Kenji ^b   Kawano, Fumio ^b   Takatsuki, Kiyoshi ^b  

^a KUMAMOTO UNIVERSITY   (Japan)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

EID: 12644301201     PISSN: 00222143     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0022-2143(97)90142-6     Document Type: Article

References (35)

1. Alexanian R, Barlogie B, Dixon D. Renal failure in multiple myeloma. Pathogenesis and prognostic implications. Arch Intern Med 1990;150:1693-5.
2. Kyle RA. Monoclonal proteins and renal disease. Annu Rev Med 1994;45:71-7.
3. Foerster J. Multiple myeloma. In: Lee GR, Bithell TC, Foerster J, Athens JW, Lukens JN, editors. Wintrobe's clinical hematology (vol 2). 9th ed. Philadelphia: Lea & Febiger, 1993:2219-49.
4. Solomon A, Weiss DT, Kattine AA. Nephrotoxic potential of Bence Jones proteins. N Engl J Med 1991;324:1846-51.
5. Sanders PW, Booker BB. Pathobiology of cast nephropathy from human Bence Jones proteins. J Clin Invest 1992;89: 630-9.
6. Huang ZQ, Kirk KA, Connelly KG, Sanders PW. Bence Jones proteins bind to a common peptide segment of Tamm-Horsfall glycoprotein to promote heterotypic aggregation. J Clin Invest 1993;92:2975-83.
7. Myatt EA, Westholm FA, Weiss DT, Solomon A, Schiffer M, Stevens FJ. Pathogenic potential of human monoclonal immunoglobulin light chains: relationship of in vitro aggregation to in vivo organ deposition. Proc Natl Acad Sci USA 1994; 91:3034-8.
8. Weiss JH, Williams RH, Galla JH, et al. Pathophysiology of acute Bence-Jones protein nephrotoxicity in the rat. Kidney Int 1981;20:198-210.
9. Johns EA, Turner R, Cooper EH, Maclennan ICM. Isoelectric points of urinary light chains in myelomatosis: analysis in relation to nephrotoxicity. J Clin Pathol 1986;39:833-7.
10. Norden AGW, Flynn FV, Fulcher LM, Richards JDM. Renal impairment in myeloma: negative association with isoelectric point of excreted Bence-Jones protein. J Clin Pathol 1989; 42:59-62.
11. Sanders PW, Booker BB, Bishop JB, Cheung HC. Mechanisms of intranephronal proteinaceous cast formation by low molecular weight proteins. J Clin Invest 1990;85:570-6.
12. Hakomori S. Aberrant glycosylation in cancer cell membranes as focused on glycolipids: overview and perspectives. Cancer Res 1985;45:2405-14.
13. Carlos TM, Harlan JM. Leukocyte-endothelial adhesion molecules. Blood 1994;84:2068-101.
14. Rademacher TW, Parekh RB, Dwek RA. Glycobiology. Annu Rev Biochem 1988;57:785-838.
15. Kobata A. Structures and functions of the sugar chains of glycoproteins. Eur J Biochem 1992;209:483-501.
16. Lis H, Sharon N. Protein glycosylation. Structural and functional aspects. Eur J Biochem 1993;218:1-27.
17. Takeuchi M, Inoue N, Strickland TW, et al. Relationship between sugar chain structure and biological activity of recombinant human erythropoietin produced in Chinese hamster ovary cells. Proc Natl Acad Sci USA 1989;86:7819-22.
18. Clamp JR, Putnam FW. The carbohydrate prosthetic group of human γ-globulin. J Biol Chem 1964;239:3233-40.
19. Sox HC, Hood L. Attachment of carbohydrate to the variable region of myeloma immunoglobulin light chains. Proc Natl Acad Sci USA 1970;66:975-82.
20. Kornfeld R, Keller J, Baenziger J, Kornfeld S. The structure of the glycopeptide of human γG myeloma proteins. J Biol Chem 1971;246:3259-68.
21. Mizuochi T, Taniguchi T, Shimizu A, Kobata A. Structural and numerical variations of the carbohydrate moiety of immunoglobulin G. J Immunol 1982;129:2016-20.
22. Deisenhofer J. Crystallographic refinement and atomic models of a human Fc fragment and its complex with fragment B of protein A from Staphylococcus aureus at 2.9- and 2.8-Å resolution. Biochemistry 1981;20:2361-70.
23. Furukawa K, Kobata A. IgG galactosylation-its biological significance and pathology. Mol Immunol 1991;28:1333-40.
24. Parekh RB, Dwek RA, Sutton BJ, et al. Association of rheumatoid arthritis and primary osteoarthritis with changes in the glycosylation pattern of total serum IgG. Nature 1985; 316:452-7.
25. Nishiura T, Fujii S, Kanayama Y, et al. Carbohydrate analysis of immunoglobulin G myeloma proteins by lectin and high performance liquid chromatography: role of glycosyltransferases in the structures. Cancer Res 1990;50: 5345-50.
26. Parekh R, Roitt I, Isenberg D, Dwek R, Rademacher T. Age-related galactosylation of the N-linked oligosaccharides of human serum IgG. J Exp Med 1988;167:1731-6.
27. Spiegelberg HL, Abel CA, Fishkin BG, Grey HM. Localization of the carbohydrate withn the variable region of light and heavy chains of human γG myeloma proteins. Biochemistry 1970;9:4217-23.
28. Ohkura T, Isobe T, Yamashita K, Kobata A. Structures of the carbohydrate moieties of two monoclonal human γ-type immunoglobulin light chains. Biochemistry 1985;24:503-8.
29. Chandrasekaran EV, Mendicino A, Garver FA, Mendicino J. Structures of sialylated O-glycosidically and N-glycosidically linked oligosaccharides in a monoclonal immunoglobulin light chain. J Biol Chem 1981;256:1549-55.
30. Garver FA, Chang LS, Kiefer CR, et al. Localization of the carbohydrate units in a human immunoglobulin light chain, protein Sm ë. Eur J Biochem 1981;115:643-52.
31. Takahashi N, Tomiya N. Analysis of N-linked oligosaccharides: application of glycoamidase A. In: Takahashi N, Muramatsu T, editors. Handbook of endoglycosidases and glycoamidases. Boca Raton: CRC Press, 1992:199-332.
32. Hase S, Ibuki T, Ikenaka T. Reexamiation of the pyridylamination used for fluorescence labeling of oligosaccharides and its application to glycoproteins. J Biochem 1984;95:197-203.
33. Tomiya N, Awaya J, Kurono M, Endo S, Arata Y, Takahashi N. Analyses of N-linked oligosaccharides using a two-dimensional mapping technique. Anal Biochem 1988;171:73-90.
34. Takahashi N, Wada Y, Awaya J, Kurono M, Tomiya N. Two-dimensional elution map of GalNAc-containing N-linked oligosaccharides. Anal Biochem 1993;208:96-109.
35. γVI subgroup of human light chains with amyloidosis AL(λ). J Clin Invest 1982;70:453-60.